These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 25890327)
1. RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1-mediated modulation of the LPS-induced activation of BV-2 microglial cells. Jung KH; Das A; Chai JC; Kim SH; Morya N; Park KS; Lee YS; Chai YG J Neuroinflammation; 2015 Feb; 12():36. PubMed ID: 25890327 [TBL] [Abstract][Full Text] [Related]
2. Dual transcriptome sequencing reveals resistance of TLR4 ligand-activated bone marrow-derived macrophages to inflammation mediated by the BET inhibitor JQ1. Das A; Chai JC; Yang CS; Lee YS; Das ND; Jung KH; Chai YG Sci Rep; 2015 Nov; 5():16932. PubMed ID: 26582142 [TBL] [Abstract][Full Text] [Related]
3. Dual RNA sequencing reveals the expression of unique transcriptomic signatures in lipopolysaccharide-induced BV-2 microglial cells. Das A; Chai JC; Kim SH; Park KS; Lee YS; Jung KH; Chai YG PLoS One; 2015; 10(3):e0121117. PubMed ID: 25811458 [TBL] [Abstract][Full Text] [Related]
4. The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line. Baek M; Yoo E; Choi HI; An GY; Chai JC; Lee YS; Jung KH; Chai YG Sci Rep; 2021 Apr; 11(1):8828. PubMed ID: 33893325 [TBL] [Abstract][Full Text] [Related]
5. 6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation. Huang HY; Chang HF; Tsai MJ; Chen JS; Wang MJ J Neuroinflammation; 2016 Apr; 13(1):78. PubMed ID: 27075886 [TBL] [Abstract][Full Text] [Related]
6. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027 [TBL] [Abstract][Full Text] [Related]
7. Microarray analysis of gene expression profile by treatment of Cinnamomi Ramulus in lipopolysaccharide-stimulated BV-2 cells. Hwang SH; Choi YG; Jeong MY; Hong YM; Lee JH; Lim S Gene; 2009 Aug; 443(1-2):83-90. PubMed ID: 19422891 [TBL] [Abstract][Full Text] [Related]
8. Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation. Toniolo PA; Liu S; Yeh JE; Moraes-Vieira PM; Walker SR; Vafaizadeh V; Barbuto JA; Frank DA J Immunol; 2015 Apr; 194(7):3180-90. PubMed ID: 25725100 [TBL] [Abstract][Full Text] [Related]
9. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury. Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146 [TBL] [Abstract][Full Text] [Related]
10. RNA sequencing reveals resistance of TLR4 ligand-activated microglial cells to inflammation mediated by the selective jumonji H3K27 demethylase inhibitor. Das A; Arifuzzaman S; Yoon T; Kim SH; Chai JC; Lee YS; Jung KH; Chai YG Sci Rep; 2017 Jul; 7(1):6554. PubMed ID: 28747667 [TBL] [Abstract][Full Text] [Related]
11. Transcriptome sequencing reveals that LPS-triggered transcriptional responses in established microglia BV2 cell lines are poorly representative of primary microglia. Das A; Kim SH; Arifuzzaman S; Yoon T; Chai JC; Lee YS; Park KS; Jung KH; Chai YG J Neuroinflammation; 2016 Jul; 13(1):182. PubMed ID: 27400875 [TBL] [Abstract][Full Text] [Related]
13. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. Belkina AC; Nikolajczyk BS; Denis GV J Immunol; 2013 Apr; 190(7):3670-8. PubMed ID: 23420887 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of BET protein BRD4 delays murine lupus. Wei S; Sun Y; Sha H Int Immunopharmacol; 2015 Dec; 29(2):314-319. PubMed ID: 26590112 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. Kremlev SG; Roberts RL; Palmer C J Neuroimmunol; 2004 Apr; 149(1-2):1-9. PubMed ID: 15020059 [TBL] [Abstract][Full Text] [Related]
16. Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells. Cobourne-Duval MK; Taka E; Mendonca P; Soliman KFA J Neuroimmunol; 2018 Jul; 320():87-97. PubMed ID: 29759145 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic intervention with a BET inhibitor ameliorates acute retinal ganglion cell death in mice. Li J; Zhao L; Urabe G; Fu Y; Guo LW Mol Vis; 2017; 23():149-159. PubMed ID: 28356707 [TBL] [Abstract][Full Text] [Related]
18. FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing. Das A; Arifuzzaman S; Kim SH; Lee YS; Jung KH; Chai YG Neuropharmacology; 2017 Jun; 119():1-14. PubMed ID: 28373076 [TBL] [Abstract][Full Text] [Related]
19. Transcriptome sequencing of microglial cells stimulated with TLR3 and TLR4 ligands. Das A; Chai JC; Kim SH; Lee YS; Park KS; Jung KH; Chai YG BMC Genomics; 2015 Jul; 16(1):517. PubMed ID: 26159724 [TBL] [Abstract][Full Text] [Related]
20. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. Dirscherl K; Karlstetter M; Ebert S; Kraus D; Hlawatsch J; Walczak Y; Moehle C; Fuchshofer R; Langmann T J Neuroinflammation; 2010 Jan; 7():3. PubMed ID: 20074346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]